Teresa M. Darragh, MD

Pathologist

Dr. Teresa M. Darragh is a pathologist who sees patients in the Cytology Service and Dysplasia Clinic. She specializes in human papilloma virus (HPV) induced anogenital neoplasia, which includes cervical and anal cancer. She is involved in research investigating HPV-related anogenital tract disease in men and women. UCSF's team of experts has been fundamental in the recognition of anal HPV-related disease and the acceptance of anal cytology as a screening tool for HPV at-risk populations.

Darragh received an medical degree at Cornell University Medical College in New York. She completed a pathology residency, followed by fellowships in surgical pathology and cytopathology at UCSF. Darragh is a member of several professional organizations, including the American Society of Clinical Pathologists, Papanicolaou Society of Cytopathology, American Society of Cytopathology, American Society for Colposcopy and Cervical Pathology (ASCCP), and the College of American Pathologists. She has received numerous honors and awards, including ASCCP's Meritorious Award of Scientific Achievement. She is a professor of clinical pathology at UCSF.

Academic Title

Professor

More about Teresa M. Darragh

Education

Cornell University 1986

Residencies

UCSF, Pathology 1988

Fellowships

UCSF, Cytopathology 1990
UCSF, Surgical Pathology 1991

Selected Research and Publications

  1. Patel P, Bush T, Kojic EM, Conley L, Unger ER, Darragh TM, Henry K, Hammer J, Escota G, Palefsky JM, Brooks JT. Prevalence, Incidence, and Clearance of Anal High-Risk Human Papillomavirus Infection Among HIV-Infected Men in the SUN Study. J Infect Dis. 2018 Mar 05; 217(6):953-963.
  2. Kojic EM, Conley L, Bush T, Cu-Uvin S, Unger ER, Henry K, Hammer J, Escota G, Darragh TM, Palefsky JM, Brooks JT, Patel P. Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study). J Infect Dis. 2018 Feb 14.
  3. Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, Mayeaux EJ, Waxman AG, Conageski C, Einstein MH, Huh WK. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. J Low Genit Tract Dis. 2017 Oct; 21(4):223-229.
  4. Wentzensen N, Massad LS, Mayeaux EJ, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, Guido RS, Jeronimo JA, Liu A, Mathews CA, Mitchell MM, Moscicki AB, Novetsky AP, Papasozomenos T, Perkins RB, Silver MI, Smith KM, Stier EA, Tedeschi CA, Werner CL, Huh WK. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. J Low Genit Tract Dis. 2017 Oct; 21(4):216-222.
  5. Massad LS, Hessol NA, Darragh TM, Minkoff H, Colie C, Wright RL, Cohen M, Seaberg EC. Cervical cancer incidence after up to 20 years of observation among women with HIV. Int J Cancer. 2017 10 15; 141(8):1561-1565.
  6. Robbins HA, Strickler HD, Massad LS, Pierce CB, Darragh TM, Minkoff H, Keller MJ, Fischl M, Palefsky J, Flowers L, Rahangdale L, Milam J, Shrestha S, Colie C, D'Souza G. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS. 2017 Apr 24; 31(7):1035-1044.
  7. Schiffman M, Wentzensen N, Khan MJ, Castle PE, Chelmow D, Huh WK, Moscicki AB, Stockdale CK, Darragh TM, Silver M, Guido RS. Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines. J Low Genit Tract Dis. 2017 04; 21(2):87-90.
  8. Ho D, Drake TK, Smith-McCune KK, Darragh TM, Hwang LY, Wax A. Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology. Int J Cancer. 2017 03 15; 140(6):1447-1456.
  9. Goldstone RN, Hasan SR, Drury S, Darragh TM, van Zante A, Goldstone SE. A trial of radiofrequency ablation for anal intraepithelial neoplasia. Int J Colorectal Dis. 2017 Mar; 32(3):357-365.
  10. Hillman RJ, Cuming T, Darragh T, Nathan M, Berry-Lawthorn M, Goldstone S, Law C, Palefsky J, Barroso LF, Stier EA, Bouchard C, Almada J, Jay N. 2016 IANS International Guidelines for Practice Standards in the Detection of Anal Cancer Precursors. J Low Genit Tract Dis. 2016 Oct; 20(4):283-91.
  11. D'Souza G, Wentz A, Wiley D, Shah N, Barrington F, Darragh TM, Joste N, Plankey M, Reddy S, Breen EC, Young S, Cranston RD. Anal Cancer Screening in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2016 Apr 15; 71(5):570-6.
  12. Khan MJ, Massad LS, Kinney W, Gold MA, Mayeaux EJ, Darragh TM, Castle PE, Chelmow D, Lawson HW, Huh WK. A Common Clinical Dilemma: Management of Abnormal Vaginal Cytology and Human Papillomavirus Test Results. J Low Genit Tract Dis. 2016 Apr; 20(2):119-25.
  13. Khan MJ, Massad LS, Kinney W, Gold MA, Mayeaux EJ, Darragh TM, Castle PE, Chelmow D, Lawson HW, Huh WK. A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results. Gynecol Oncol. 2016 05; 141(2):364-370.
  14. Darragh TM. The LAST Project and the diagnostic bottom line. Cytopathology. 2015 Dec; 26(6):343-5.
  15. Massad LS, Xie X, Burk RD, D'Souza G, Darragh TM, Minkoff H, Colie C, Burian P, Palefsky J, Atrio J, Strickler HD. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol. 2016 Mar; 214(3):354.e1-6.
  16. Conley LJ, Bush TJ, Darragh TM, Palefsky JM, Unger ER, Patel P, Steinau M, Kojic EM, Martin H, Overton ET, Cu-Uvin S, Hammer J, Henry K, Wood K, Brooks JT. Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy. J Infect Dis. 2016 Feb 01; 213(3):351-60.
  17. Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS. Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1548-56.
  18. Jay N, Berry JM, Miaskowski C, Cohen M, Holly E, Darragh TM, Palefsky JM. Colposcopic Characteristics and Lugol's Staining Differentiate Anal High-Grade and Low-Grade Squamous Intraepithelial Lesions During High Resolution Anoscopy. Papillomavirus Res. 2015 Dec; 1:101-108.
  19. Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, Chiao E, Einstein MH, Goldstone SE, Jay N, Likes WM, Stier EA, Welton ML, Wiley DJ, Palefsky JM. Screening for Anal Cancer in Women. J Low Genit Tract Dis. 2015 Jul; 19(3 Suppl 1):S27-42.
  20. Crothers BA, Darragh TM, Tambouret RH, Nayar R, Barkan GA, Zhao C, Booth CN, Padmanabhan V, Tabatabai ZL, Souers RJ, Thomas N, Wilbur DC, Moriarty AT. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire. Arch Pathol Lab Med. 2016 Jan; 140(1):13-21.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.